Energy Metabolism in Cancer

Anderson N, Mucka P, Kern Jea. The emerging role and targetability of the TCA cycle in cancer metabolism. Protein cells. 2018;9(2):216-37.

Gasmi A, Peana M, al. Ae. Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis. Archives of Toxicology. 2021;95(4):1161-78.

Bartkova J, Rezaei N, Liontos ea. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006;444(7119):633-7.

Warburg O, Wind F, al. Ne. The metabolism of tumors in the body. The Journal of general physiology. 1927;8(6):519.

Liberti M, Locasale J. The Warburg effect: how does it benefit cancer cells? Trends in biochemical sciences. 2016;41(3):211-8.

Ohta S. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene. 2006;25(34):4768-76.

Reichert AS, Neupert W. Mitochondriomics or what makes us breathe. Trends in genetics. 2004;20(11):555-62.

Yang Y, Karakhanova S, al. He. Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy. Journal of cellular physiology. 2016;231(12):2570-81.

Grasso D, Zampieri LX, al. Ce. Mitochondria in cancer. Cell stress. 2020;4(6):114.

Chandel N, Maltepe E, al. Ge. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proceedings of the National Academy of Sciences. 1998;95(20):11715-20.

Di Benedetto G, Scalzotto E, al. Me. Mitochondrial Ca2+ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels. Cell metabolism. 2013;17(6):965-75.

Bravo-Sagua R, E Rodriguez A, Kuzmicic ea. Cell death and survival through the endoplasmic reticulum-mitochondrial axis. Current molecular medicine. 2013;13(2):317-29.

Hardie DG, Lin S-C. AMP-activated protein kinase–not just an energy sensor. F1000Research. 2017;6:1724.

Hao W, Chang C, al. Te. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. Journal of Biological Chemistry. 2010;285(17):12647-54.

Vaupel P, Höckel M, al. Me. Detection and characterization of tumor hypoxia using pO2 histography. Antioxidants & redox signaling. 2007;9(8):1221-36.

Cairns R, Harris I, Mak T. Regulation of cancer cell metabolism. Nature Reviews Cancer. 2011;11(2):85-95.

Miricescu D, Totan A, al. S-Se. PI3K/AKT/mTOR signaling pathway in breast cancer: From molecular landscape to clinical aspects. International journal of molecular sciences. 2020;22(1):173.

Shackelford D, Shaw R. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression. Nature Reviews Cancer. 2009;9(8):563-75.

Hsu C-C, Peng D, al. Ce, editors. AMPK signaling and its targeting in cancer progression and treatment. Seminars in Cancer Biology; 2022: Elsevier.

Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future oncology. 2010;6(3):457-70.

Kim J, Yang G, al. Ke. AMPK activators: mechanisms of action and physiological activities. Experimental & molecular medicine. 2016;48(4):e224-e.

Shirwany NA, Zou M-H. AMPK: a cellular metabolic and redox sensor. A minireview. Frontiers in bioscience (Landmark edition). 2014;19:447.

Xiao B, Sanders M, al. Ue. Structure of mammalian AMPK and its regulation by ADP. Nature. 2011;472(7342):230-3.

Xiang H, Zhang J, al. Le. Targeting autophagy-related protein kinases for potential therapeutic purpose. Acta Pharmaceutica Sinica B. 2020;10(4):569-81.

Mailloux R, Beriault R, al. Le. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. J PloS one. 2007;2(8):e690.

Patra K, Hay N. The pentose phosphate pathway and cancer. Trends in biochemical sciences. 2014;39(8):347-54.

Hong S, Park C, al. Ke. NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer. Oncogenesis. 2016;35(27):3544-54.

Nikiforov A, Kulikova V, Ziegler M. The human NAD metabolome: Functions, metabolism and compartmentalization. Critical reviews in biochemistry

molecular biology. 2015;50(4):284-97.

Rich P. The molecular machinery of Keilin's respiratory chain. Biochemical society transactions. 2003:1095-105.

Forbes SA, Bindal N, al. Be. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic acids research. 2010;39(suppl_1):D945-D50.

Hanahan D, al. We. Hallmarks of cancer: the next generation. cell. 2011;144(5):646-74.

Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960-76.

Rodriguez-Viciana PW, Patricia H Dhand et al. Phosphatidylinositol-3-OH kinase direct target of Ras. Nature. 1994;370(6490):527-32.

Faivre S, Kroemer G, al. Re. Current development of mTOR inhibitors as anticancer agents. Nature reviews Drug discovery. 2006;5(8):671-88.

Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing research reviews. 2012;11(2):230-41.

Martina JA, Chen Y, al. Ge. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012;8(6):903-14.

Deng L, Chen L, al. Ze. Ubiquitination of Rheb governs growth factor-induced mTORC1 activation. Cell research. 2019;29(2):136-50.

Hua H, Kong Q, al. Ze. Targeting mTOR for cancer therapy. Journal of hematology & oncology. 2019;12(1):1-19.

Chin RM, Fu X, al. Pe. The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature. 2014;510(7505):397-401.

Inoki K, Ouyang H, al. Ze. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006;126(5):955-68.

Yin Y, Hua H, al. Le. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR. Cell research. 2016;26(1):46-65.

Liu P, Gan W, al. Ie. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nature cell biology. 2013;15(11):1340-50.

Liu P, Gan W, al. Ce. PtdIns (3, 4, 5) P3-Dependent Activation of the mTORC2 Kinase ComplexPtdIns (3, 4, 5) P3 Activates mTORC2 by Binding the SIN1-PH Domain. Cancer discovery. 2015;5(11):1194-209.

Gao M, Kong Q, al. He. AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin. Oncotarget. 2016;7(13):16349.

Moloughney JGK, Peter K, al. V-Ce. mTORC2 responds to glutamine catabolite levels to modulate the hexosamine biosynthesis enzyme GFAT1. Molecular cell. 2016;63(5):811-26.

Moloughney JGV-C, Nicole M Liu et al. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation. Journal of Biological Chemistry. 2018;293(42):16464-78.

Organization WH. World health statistics 2016: monitoring health for the SDGs sustainable development goals: World Health Organization; 2016.

Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutrition & metabolism. 2010;7:1-22.

Margulis L. Origin of eukaryotic cells: Evidence and research implications for a theory of the origin and evolution of microbial, plant and animal cells on the precambrian Earth: Yale University Press; 1970.

Davila AF, Zamorano P. Mitochondria and the evolutionary roots of cancer. Physical Biology. 2013;10(2):026008.

VanItallie TB, Nufert TH. Ketones: metabolism's ugly duckling. Nutrition reviews. 2003;61(10):327-41.

Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins, leukotrienes and essential fatty acids. 2004;70(3):309-19.

Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell metabolism. 2016;23(1):27-47.

Hanahan D, al. Ce. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer cell. 2012;21(3):309-22.

Goetze K, Walenta S, al. Ke. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. International journal of oncology. 2011;39(2):453-63.

Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nature Reviews Cancer. 2021;21(10):669-80.

Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nature reviews Molecular cell biology. 2020;21(4):183-203.

Huang F, Ni M, al. Ce. Inosine monophosphate dehydrogenase dependence in a subset of small cell lung cancers. Cell metabolism. 2018;28(3):369-82. e5.

William W, Kim J-S, al. Le. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Annals of oncology. 2012;23(1):78-85.

Li C, Liu VW, al. Ce. Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer. Molecular cancer. 2014;13(1):1-12.

Villani LA, Smith BK, al. Me. The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration. Molecular metabolism. 2016;5(10):1048-56.

Jeon S-M, Chandel NS, al. He. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 2012;485(7400):661-5.